Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
2-Year Results With a Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions: The First-in-Human ILLUMINA Study.
Steiner S, Honton B, Langhoff R, Chiesa R, Kahlberg A, Thieme M, Zeller T, Garot P, Commeau P, Cremonesi A, Marone EM, Sauguet A, Scheinert D. Steiner S, et al. Among authors: sauguet a. JACC Cardiovasc Interv. 2022 Mar 28;15(6):618-626. doi: 10.1016/j.jcin.2021.12.034. Epub 2022 Feb 23. JACC Cardiovasc Interv. 2022. PMID: 35219622 Free article.
[Atherosclerotic renal artery stenosis].
Sauguet A, Honton B. Sauguet A, et al. Ann Cardiol Angeiol (Paris). 2014 Dec;63(6):437-41. doi: 10.1016/j.ancard.2014.09.034. Epub 2014 Oct 11. Ann Cardiol Angeiol (Paris). 2014. PMID: 25450992 Review. French.
Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results.
Lammer J, Bosiers M, Deloose K, Schmidt A, Zeller T, Wolf F, Lansink W, Sauguet A, Vermassen F, Lauwers G, Scheinert D, Popma JJ, McGreevy R, Rapoza R, Schwartz LB, Jaff MR. Lammer J, et al. Among authors: sauguet a. JACC Cardiovasc Interv. 2016 Jun 13;9(11):1178-87. doi: 10.1016/j.jcin.2016.02.051. JACC Cardiovasc Interv. 2016. PMID: 27282601 Free article. Clinical Trial.
Femoropopliteal In-stent Restenosis Repair: Midterm Outcomes After Paclitaxel Eluting Balloon Use (PLAISIR Trial).
Bague N, Julia P, Sauguet A, Pernès JM, Chatelard P, Garbé JF, Penillon S, Cardon JM, Commeau P, Planché O, Guyomarch B, Gouëffic Y. Bague N, et al. Among authors: sauguet a. Eur J Vasc Endovasc Surg. 2017 Jan;53(1):106-113. doi: 10.1016/j.ejvs.2016.10.002. Epub 2016 Nov 24. Eur J Vasc Endovasc Surg. 2017. PMID: 27890526 Free article. Clinical Trial.
Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
Bausback Y, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D; RANGER SFA Investigators. Bausback Y, et al. Among authors: sauguet a. J Endovasc Ther. 2017 Aug;24(4):459-467. doi: 10.1177/1526602817710770. Epub 2017 May 31. J Endovasc Ther. 2017. PMID: 28558502 Clinical Trial.
12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D; RANGER SFA Investigators. Steiner S, et al. Among authors: sauguet a. JACC Cardiovasc Interv. 2018 May 28;11(10):934-941. doi: 10.1016/j.jcin.2018.01.276. Epub 2018 May 2. JACC Cardiovasc Interv. 2018. PMID: 29730375 Free article. Clinical Trial.
[Lower extremity arteriopathy disease in the elderly: A systematic review].
Honton B, Mastrokostopoulos A, Philippart R, Sauguet A, Leger P. Honton B, et al. Among authors: sauguet a. Ann Cardiol Angeiol (Paris). 2018 Dec;67(6):450-454. doi: 10.1016/j.ancard.2018.10.004. Epub 2018 Oct 19. Ann Cardiol Angeiol (Paris). 2018. PMID: 30343821 French.
35 results